Differentiating EPA from EPA/DHA in cardiovascular risk reduction
None of the clinical trials of omega-3 fatty acids using combinations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were able to show any effect on cardiovascular outcomes, despite reductions in triglyceride levels. In contrast, the Reduction of Cardiovascular Events With Icosapent E...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2022-05-01
|
| Serie: | American Heart Journal Plus |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2666602222000659 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|